Technical ProgressWorld Gene Therapy Research Report 2018: Technologies, Markets and Companies Analysis & Forecasts 2017-2027 …Business Wire (press release)Gene therapy technologies are described in detail including viral vectors, nonviral vector… Continue reading
NasdaqGene therapy biotech MeiraGTx sets terms for $75 million IPONasdaqMeiraGTx Holdings, which is developing gene therapies for disorders of the eye and salivary gland, announced terms for its IPO on Tuesday. The New York, NY-based company plans to r… Continue reading
NasdaqGene therapy biotech MeiraGTx sets terms for $75 million IPONasdaqMeiraGTx Holdings, which is developing gene therapies for disorders of the eye and salivary gland, announced terms for its IPO on Tuesday. The New York, NY-based company plans to r… Continue reading
Tech TimesCRISPR used to block AIDS virus replicating in cellsBioNewsScientists in Japan have harnessed genome editing to successfully block the AIDS virus from replicating inside infected cells. The team at Kobe University used CRISPR/Cas9 to remove t… Continue reading
Investor OpinionGlobal Cancer Gene Therapy Market Forecast to Grow at a CAGR of …Clean TechnologyCancer Gene Therapy Market report provides in-depth analysis of leading players with company profiles and strategies. Cancer Gene Therapy industry delive… Continue reading
Investor OpinionGlobal Cancer Gene Therapy Market Forecast to Grow at a CAGR of …Clean TechnologyCancer Gene Therapy Market report provides in-depth analysis of leading players with company profiles and strategies. Cancer Gene Therapy industry delive… Continue reading
Genetic Engineering & Biotechnology NewsGene Therapy Ever More Common for Rare DisordersGenetic Engineering & Biotechnology NewsResurgent across the biomedical engineering and clinical trial landscape, gene-therapy owes its new vitality to a better und… Continue reading
Proactive Investors UK |
Positive House Dust Mite Immunotherapy Results for UK Biotech
Labiotech.eu (blog) British biotech Allergy Therapeutics reports positive early-stage results for its house dust mite immunotherapy. It’s been a good month for Allergy Therapeutics, which also reported positive Phase II results for its grass pollen allergy vaccine trial … Aimmune Therapeutics (AIMT) Announces Data on Terminology Used with Oral Immunotherapy Were Presented at …StreetInsider.com Allergy Therapeutics plc – Positive new data with house-dust mite immunotherapyNasdaq Allergy Therapeutics plc – Positive new data with house-dust mite …GlobeNewswire (press release) Shares magazine –Proactive Investors UK –DirectorsTalk Interviews all 7 news articles » |